Personalized iTBS for Depression: Faster, Targeted Brain Stimulation
Official title: Frequency and E-field Enhancement of iTBS for Depression (FREED)
Funded at University of California, San Diego · NIH-11569546 · Data updated 2026-11-12
A personalized, time-efficient brain stimulation approach may help people with treatment-resistant depression achieve better relief using tailored iTBS settings.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | September 1, 2026 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $287,841 |
| NIH project number | 3R33MH129471-03S1 |
| Project ID | NIH-11569546 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with treatment-resistant depression who are eligible for iTBS therapy and able to undergo transcranial magnetic stimulation.
✕Less likely to help
Individuals not responding to iTBS personalization or with contraindications to TMS may not experience benefit.
What this research studies
This project aims to tailor intermittent theta burst stimulation (iTBS) for people with treatment-resistant depression by adjusting stimulation frequency and brain target areas to match each patient’s own brain rhythms. By focusing on theta-gamma coupling and individualized parameters, the study seeks to improve remission rates while delivering treatment in a shorter daily session. Participants would undergo non-invasive brain stimulation with careful monitoring of mood and clinical outcomes to see if personalization offers added benefit. The research will be conducted at UC San Diego, led by Dr. Zafiris (Z. Daskalakis) and team, and will build on existing rTMS evidence in depression.
Why it matters
Potential benefit: If successful, patients with TRD could experience higher remission rates with shorter daily treatments.
How similar studies have gone: Previous iTBS approaches are non-inferior to rTMS; this study tests added personalization to improve efficacy.
Where this research is happening
-
University of California, San Diego
La Jolla, United States Active
Researchers
- Principal investigator: Daskalakis, Zafiris J. — University of California, San Diego
- Study coordinator: Daskalakis, Zafiris J.
Related research
Other NIH-funded projects on the same topics.
-
Biotype-based Personalization of Antidepressant Augmentation in Late-Life Depression
A multi-site study will test a computer-guided approach to choosing the best augmentation option for older adults with treatment-resistant depression.
-
Suubi-Mhealth: a mobile app to help Ugandan youth with HIV manage depression and ART adherence
A mobile app designed for 14–17 year olds in Uganda aims to support mental health and keep HIV treatment on track.
-
Group-based postpartum depression prevention: in-person vs. virtual delivery
A large study is testing whether the ROSE group program delivered virtually to pregnant people is just as helpful as the in-person version in preventing postpartum depression.
-
DESCANSO: A friendly CBT plan to ease depression, sleep problems, and fatigue in Latino cancer patients
A Spanish-speaking CBT program called DESCANSO is being tested to help Latino cancer patients feel less tired, sleep better, and happier.
-
Ultrasound-guided brain circuit targets for treatment-resistant depression
This grant tests whether focused ultrasound can safely and reversibly adjust brain circuits linked to negative mood in people with treatment-resistant depression.
-
Biotype-based Treatment Personalization for Resistant Late-Life Depression
A multi-site study will test a personalized treatment approach for older adults with depression who haven’t responded to initial antidepressants, using a machine-learning tool to guide augmentation choices.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.